Chemoprevention of Prostate Cancer: What Can Be Recommended to Patients?

Overview

Journal Curr Urol Rep

Publisher Current Science

Specialty Urology

Date 2009 Apr 18

PMID 19371472

Citations 7

Authors

Janet L Colli

Christopher L Amling

Affiliations

Soon will be listed here.

Abstract

Prostate cancer is third to lung and colon cancer as the cause of cancer-related deaths in American men. It is estimated that there will have been more than 28,000 deaths and 186,000 new cases in 2008 that will impose a significant burden on national health care costs. Chemoprevention aims to reduce both incidence and mortality through the use of agents to prevent, reverse, or delay the carcinogenic process. This study provides clinicians with information on some chemoprevention agents that have been considered to reduce prostate cancer risks, including 5-alpha-reductase inhibitors; statins (a class of compounds used to reduce cholesterol); NSAIDs; selenium; vitamins E and D; lycopene; allium vegetables (garlic, scallions, onions, chives, and leeks); soy/isoflavones; and green tea polyphenols. The evidence to support prostate cancer risk reduction benefits for each chemoprevention agent based on a review of the literature is provided.

Citing Articles

Role of traditional Islamic and Arabic plants in cancer therapy.

Ahmad R, Ahmad N, Naqvi A, Shehzad A, Al-Ghamdi M J Tradit Complement Med. 2017; 7(2):195-204.

PMID: 28417090 PMC: 5388086. DOI: 10.1016/j.jtcme.2016.05.002.

Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.

Jarrard D, Konety B, Huang W, Downs T, Kolesar J, Kim K Am J Clin Exp Urol. 2016; 4(2):17-27.

PMID: 27766277 PMC: 5069272.

Future directions in the prevention of prostate cancer.

Thompson Jr I, Cabang A, Wargovich M Nat Rev Clin Oncol. 2013; 11(1):49-60.

PMID: 24281061 PMC: 5034727. DOI: 10.1038/nrclinonc.2013.211.

Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms.

Zaid H, Silbermann M, Ben-Arye E, Saad B Evid Based Complement Alternat Med. 2011; 2012:349040.

PMID: 22203868 PMC: 3235667. DOI: 10.1155/2012/349040.

Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo.

Karna P, Gundala S, Gupta M, Shamsi S, Pace R, Yates C Carcinogenesis. 2011; 32(12):1872-80.

PMID: 21948980 PMC: 3220609. DOI: 10.1093/carcin/bgr215.

References

Tsukamoto S, Akaza H, Onozawa M, Shirai T, Ideyama Y . A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats. Cancer. 1998; 82(3):531-7. DOI: 10.1002/(sici)1097-0142(19980201)82:3<531::aid-cncr15>3.0.co;2-2. View

Li H, Stampfer M, Hollis J, Mucci L, Gaziano J, Hunter D . A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007; 4(3):e103. PMC: 1831738. DOI: 10.1371/journal.pmed.0040103. View

Kavanaugh C, Trumbo P, Ellwood K . The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst. 2007; 99(14):1074-85. DOI: 10.1093/jnci/djm037. View

Kikuchi N, Ohmori K, Shimazu T, Nakaya N, Kuriyama S, Nishino Y . No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br J Cancer. 2006; 95(3):371-3. PMC: 2360636. DOI: 10.1038/sj.bjc.6603230. View

Hodge A, English D, McCredie M, Severi G, Boyle P, Hopper J . Foods, nutrients and prostate cancer. Cancer Causes Control. 2004; 15(1):11-20. DOI: 10.1023/B:CACO.0000016568.25127.10. View

Peters U, Leitzmann M, Chatterjee N, Wang Y, Albanes D, Gelmann E . Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007; 16(5):962-8. DOI: 10.1158/1055-9965.EPI-06-0861. View

Jian L, Lee A, Binns C . Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr. 2007; 16 Suppl 1:453-7. View

Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D . Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol. 2004; 172(4 Pt 1):1314-7. DOI: 10.1097/01.ju.0000139320.78673.2a. View

Key T, Appleby P, Allen N, Travis R, Roddam A, Jenab M . Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr. 2007; 86(3):672-81. DOI: 10.1093/ajcn/86.3.672. View

10.

Yoshizawa K, Willett W, Morris S, Stampfer M, Spiegelman D, Rimm E . Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998; 90(16):1219-24. DOI: 10.1093/jnci/90.16.1219. View

11.

Perron L, Bairati I, Moore L, Meyer F . Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer. 2003; 106(3):409-15. DOI: 10.1002/ijc.11250. View

12.

Mills P, Beeson W, Phillips R, Fraser G . Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer. 1989; 64(3):598-604. DOI: 10.1002/1097-0142(19890801)64:3<598::aid-cncr2820640306>3.0.co;2-6. View

13.

Colli J, Amling C . Exploring causes for declining prostate cancer mortality rates in the United States. Urol Oncol. 2008; 26(6):627-33. DOI: 10.1016/j.urolonc.2007.05.016. View

14.

Brawley O . The potential for prostate cancer chemoprevention. Rev Urol. 2006; 4 Suppl 5:S11-7. PMC: 1476013. View

15.

Bologna M, Muzi P, Biordi L, Festuccia C, Vicentini C . Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro. Urology. 1995; 45(2):282-90. DOI: 10.1016/0090-4295(95)80019-0. View

16.

Huggins C, Hodges C . Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol. 2002; 168(1):9-12. DOI: 10.1016/s0022-5347(05)64820-3. View

17.

Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S . Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 2007; 167(1):71-7. DOI: 10.1093/aje/kwm249. View

18.

Morton M, Arisaka O, Miyake N, Morgan L, Evans B . Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr. 2002; 132(10):3168-71. DOI: 10.1093/jn/131.10.3168. View

19.

Grant W . An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002; 94(6):1867-75. DOI: 10.1002/cncr.10427. View

20.

Habel L, Zhao W, Stanford J . Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control. 2002; 13(5):427-34. DOI: 10.1023/a:1015788502099. View